About Us

Cambridge Cancer Genomics (CCG) is a Y Combinator backed healthtech startup building tools to enable oncologists to make the best therapeutic decisions for their patients.
Our Mission

We exist to ensure that each patient gets the right drug, at the right time, to beat their cancer.

To do this, we apply advances in machine learning and artificial intelligence to some of the world’s largest cancer datasets. Our technology can detect relapse earlier, predict response to therapy more accurately & reduce ineffective treatment regimens. Our operating system, OncOS, makes these data accessible to oncologists and helps power adoption of precision oncology. Our biomarker discovery engine, OncAI, helps pharmaceutical companies with complex biomarker discovery for clinical trial stratification and patient selection. We are working with clinical and academic partners worldwide to power a new generation of cancer treatment.Ultimately, our work will help ensure that each patient gets the right drug, at the right time, to beat their cancer.

Join our growing team

We are expanding our team in Cambridge, UK; offering a fantastic opportunity for dedicated individuals who are comfortable in a high-work high-reward environment, and who are enthusiastic for a dynamic and varied role.

We are looking for people who fit well into our team and company culture, and who like to overcome challenges and drive the business forward. In exchange, we offer a competitive salary with generous stock options, alongside excellent career development opportunities in a fast-growing start-up with a chance to truly impact how cancer is treated.

GEt in touch

Contact us

CCG is actively engaging in partnerships with cancer clinics, academic institutes, biotech startups, and pharmaceutical companies. Get in touch to see how we can work together.

General enquiries


Press enquiries



72 Hills Road,
Cambridge, UK,